Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chronic Disease
100%
Androgens
100%
Age-related Illnesses
100%
Testosterone
100%
Functional Limitations
100%
Selective Androgen Receptor Modulator
100%
Muscle Strength
42%
Randomized Trial
28%
Older Men
28%
Testosterone Replacement Therapy
28%
Functional Improvement
28%
Muscle Mass
28%
Anabolic Effect
28%
Sex Differences
14%
Healthy Individuals
14%
Depressive Symptoms
14%
Erectile Function
14%
Late-onset
14%
Non-steroidal
14%
Transcriptional Activity
14%
Weight Loss
14%
Mobility Limitation
14%
Androgen Receptor
14%
Anabolic Steroids
14%
Walking Speed
14%
Progression to Diabetes
14%
Steroidal
14%
Hypogonadal Men
14%
Lean Body Mass
14%
Physical Limitations
14%
Unexplained Anemia
14%
Athletic Performance
14%
Areal Bone Mineral Density (aBMD)
14%
Combined Administration
14%
Menopausal Women
14%
Aerobic Capacity
14%
Low Testosterone
14%
Functions Activities
14%
Cardiovascular Safety
14%
Strength Gain
14%
Persistent Depressive Disorder
14%
Volumetric Bone Mineral Density (vBMD)
14%
Non-steroidal Ligands
14%
Prostate Safety
14%
Mass Gain
14%
Neuromuscular Adaptation
14%
Functional Exercise
14%
Muscularity
14%
Estimated Bone Strength
14%
Narrative Review
14%
HIV-infected Patients
14%
Leg Power
14%
Medicine and Dentistry
Chronic Disease
100%
Androgen
100%
Functional Limitation
100%
Testosterone
100%
Selective Androgen Receptor Modulator
100%
Anemia
10%
Diabetes
10%
Muscle Strength
10%
Human Immunodeficiency Virus
10%
Athletes
10%
Walking Speed
10%
Walking Difficulty
10%
Androgen Receptor
10%
Anabolic Agent
10%
Bone Density
10%
Lean Body Weight
10%
Bone Strength
10%
Athletic Performance
10%
Depressive Disorder
10%
Cardiovascular System
10%
Erectile Function
10%
Sex Differences
10%
Sexual Desire
10%
Sexual Behavior
10%
Empirical evidence
10%